These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 5562719)

  • 1. A comparison of subcutaneous, nasal, and combined influenza vaccination. I. Antigenicity.
    Gwaltney JM; Edmondson WP; Rothenberg R; White PW
    Am J Epidemiol; 1971 Jun; 93(6):472-9. PubMed ID: 5562719
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of subcutaneous, nasal, and combined influenza vaccination. II. Protection against natural challenge.
    Edmondson WP; Rothenberg R; White PW; Gwaltney JM
    Am J Epidemiol; 1971 Jun; 93(6):480-6. PubMed ID: 5562720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiinfluenzal vaccination with aerosol administration in subjects belonging to a closed community].
    Zardi O; Gabrielli G; Adorisio E; Lolli C; Lancetta A
    Nuovi Ann Ig Microbiol; 1971; 22(4):243-54. PubMed ID: 5146065
    [No Abstract]   [Full Text] [Related]  

  • 4. Purified influenza vaccine: clinical and serologic responses to varying doses and different routes of immunization.
    Phillips CA; Forsyth BR; Christmas WA; Gump DW; Whorton EB; Rogers I; Rudin A
    J Infect Dis; 1970; 122(1):26-32. PubMed ID: 5433710
    [No Abstract]   [Full Text] [Related]  

  • 5. A new subunit influenza vaccine: acceptability compared with standard vaccines and effect of dose on antigenicity.
    Ruben FL; Jackson GG
    J Infect Dis; 1972 Jun; 125(6):656-64. PubMed ID: 4556572
    [No Abstract]   [Full Text] [Related]  

  • 6. Single-dose monovalent A 2 -Hong Kong influenza vaccine. Efficacy 14 months after immunization.
    Foy HM; Cooney MK; McMahan R; Bor E; Grayston JT
    JAMA; 1971 Aug; 217(8):1067-71. PubMed ID: 5109428
    [No Abstract]   [Full Text] [Related]  

  • 7. Neutralization antibody response to A2 Hong Kong influenza vaccine and its duration in school age children.
    Hosai H; Omura S; Maeda A; Kunita N
    Biken J; 1970 Dec; 13(4):277-87. PubMed ID: 5510350
    [No Abstract]   [Full Text] [Related]  

  • 8. Nasal and circulating antibody responses to influenza vaccination and their importance in resistance to infection.
    Tyrrell DA; Buckland RA; Schild GC; Freestone DS; Chinn S; Slepushkin AN
    Postgrad Med J; 1973 Mar; 49(569):200-2. PubMed ID: 4802537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine.
    Fedson DS; Fulk RV; Huber MA; Reisberg MA; Kasel JA
    J Immunol; 1971 Sep; 107(3):730-7. PubMed ID: 4999093
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antiviral inhibitors and antibodies in the serum of subjects vaccinated against influenza].
    Kazakova VN; Kupriashina LM
    Vopr Virusol; 1971; 16(6):651-5. PubMed ID: 5141610
    [No Abstract]   [Full Text] [Related]  

  • 11. Live influenza B vaccine in volunteers. A report to the Medical Research Council by their Committee on Influenza and Other Respiratory Virus Vaccines.
    Beare AS; Tyrrell DA; Hobson D; Howells CH; Pereira MS; Pollock TM; Tyler LE
    J Hyg (Lond); 1969 Mar; 67(1):1-11. PubMed ID: 5278156
    [No Abstract]   [Full Text] [Related]  

  • 12. EFFECT OF DOSAGE ON ANTIBODY RESPONSE TO POLYVALENT INFLUENZA VIRUS VACCINE IN AN AGED POPULATION.
    SASLAW S; CARLISLE HN
    Am J Med Sci; 1964 Sep; 248():273-84. PubMed ID: 14210303
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. II. Clinical reactions, hemagglutination-inhibitiong and strain and type-specific complement-fixing antibody responses in infants.
    Závadová H; Adam E; Vonka V; Domorázková E; Kratochvílová M; Burian V; Davenport FM
    Arch Gesamte Virusforsch; 1972; 36(1):53-61. PubMed ID: 5062439
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to intradermal vaccination with A2, Hong Kong variant, influenza vaccine.
    McElroy JT; Szwed JJ
    N Engl J Med; 1969 Nov; 281(19):1076. PubMed ID: 5343531
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlated studies of a recombinant influenza-virus vaccine. IV. Protection against naturally occurring influenza in military trainees.
    Leibovitz A; Coultrip RL; Kilbourne ED; Legters LJ; Smith CD; Chin J; Schulman JL
    J Infect Dis; 1971 Nov; 124(5):481-7. PubMed ID: 5115671
    [No Abstract]   [Full Text] [Related]  

  • 16. Influenza immunization: field trial on a university campus.
    Waldman RH; Coggins WJ
    J Infect Dis; 1972 Sep; 126(3):242-8. PubMed ID: 4559743
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of an influenza immunization program.
    Brown AJ
    Arch Environ Health; 1966 May; 12(5):597-9. PubMed ID: 5930651
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: Intradermal influenza vaccination.
    Payler DK; Skirrow MB
    Br Med J; 1974 Jun; 2(5921):727. PubMed ID: 4852830
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of intranasal and parenteral immunization routes for influenza in mice.
    Provost PJ; DeMello GC; Vasington PJ
    Can J Microbiol; 1971 Aug; 17(8):1119-24. PubMed ID: 5096403
    [No Abstract]   [Full Text] [Related]  

  • 20. Revised (1972-1973) bivalent influenza vaccine. Serum and nasal antibody responses to parenteral vaccination.
    Wenzel RP; Hendley JO; Sande MA; Gwaltney JM
    JAMA; 1973 Oct; 226(4):435-8. PubMed ID: 4800234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.